Herlyn M - Search Results

1

The functional interplay between EGFR overexpression, hTERT activation, and p53 mutation in esophageal epithelial cells with activation of stromal fibroblasts induces tumor development, invasion, and differentiation.

Okawa T, Michaylira CZ, Kalabis J, Stairs DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry WS, Cukierman E, Herlyn M, Rustgi AK. Okawa T, et al. Among authors: herlyn m. Genes Dev. 2007 Nov 1;21(21):2788-803. doi: 10.1101/gad.1544507. Genes Dev. 2007. PMID: 17974918 Free PMC article.

2

Regulatory pathways in tumor growth and invasion.

Herlyn M, Malkowicz SB. Herlyn M, et al. Lab Invest. 1991 Sep;65(3):262-71. Lab Invest. 1991. PMID: 1890806 Review.

3

p73beta, unlike p53, suppresses growth and induces apoptosis of human papillomavirus E6-expressing cancer cells.

Prabhu NS, Somasundaram K, Satyamoorthy K, Herlyn M, El-Deiry WS. Prabhu NS, et al. Among authors: herlyn m. Int J Oncol. 1998 Jul;13(1):5-9. doi: 10.3892/ijo.13.1.5. Int J Oncol. 1998. PMID: 9625796

4

Ultraviolet B-induced squamous epithelial and melanocytic cell changes in a xenograft model of cancer development in human skin.

Sauter ER, Klein-Szanto AJ, Atillasoy E, Montone KT, Goodrow T, Binder RL, Seykora JT, Herlyn M. Sauter ER, et al. Among authors: herlyn m. Mol Carcinog. 1998 Nov;23(3):168-74. Mol Carcinog. 1998. PMID: 9833777

5

Induction of p21(WAF1/CIP1) and inhibition of Cdk2 mediated by the tumor suppressor p16(INK4a).

Mitra J, Dai CY, Somasundaram K, El-Deiry WS, Satyamoorthy K, Herlyn M, Enders GH. Mitra J, et al. Among authors: herlyn m. Mol Cell Biol. 1999 May;19(5):3916-28. doi: 10.1128/MCB.19.5.3916. Mol Cell Biol. 1999. PMID: 10207115 Free PMC article.

6

Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.

Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M. Sauter ER, et al. Among authors: herlyn m. Clin Cancer Res. 1999 Apr;5(4):775-82. Clin Cancer Res. 1999. PMID: 10213212

7

The administration schedule of cyclin-dependent kinase inhibitor gene therapy and etoposide chemotherapy is a major determinant of cytotoxicity.

Prabhu NS, Somasundaram K, Tian H, Enders GH, Satyamoorthy K, Herlyn M, El-Deiry WS. Prabhu NS, et al. Among authors: herlyn m. Int J Oncol. 1999 Aug;15(2):209-16. doi: 10.3892/ijo.15.2.209. Int J Oncol. 1999. PMID: 10402229

8

Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas.

Sauter ER, Nesbit M, Litwin S, Klein-Szanto AJ, Cheffetz S, Herlyn M. Sauter ER, et al. Among authors: herlyn m. Cancer Res. 1999 Oct 1;59(19):4876-81. Cancer Res. 1999. PMID: 10519399

9

Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

Satyamoorthy K, Chehab NH, Waterman MJ, Lien MC, El-Deiry WS, Herlyn M, Halazonetis TD. Satyamoorthy K, et al. Among authors: herlyn m. Cell Growth Differ. 2000 Sep;11(9):467-74. Cell Growth Differ. 2000. PMID: 11007451

10

Insulin-like growth factor-I-induced migration of melanoma cells is mediated by interleukin-8 induction.

Satyamoorthy K, Li G, Vaidya B, Kalabis J, Herlyn M. Satyamoorthy K, et al. Among authors: herlyn m. Cell Growth Differ. 2002 Feb;13(2):87-93. Cell Growth Differ. 2002. PMID: 11864912

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

680 results

Search Page

Filters